Cargando…

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies

Serum neurofilament light chain (NfL) has been shown to correlate with neuroaxonal damage in multiple sclerosis (MS) and various other neurological diseases. While serum NfL is now regularly reported in clinical approval studies, there is a lack of longitudinal data from patients treated with establ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huss, André, Senel, Makbule, Abdelhak, Ahmed, Mayer, Benjamin, Kassubek, Jan, Ludolph, Albert C., Otto, Markus, Tumani, Hayrettin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555392/ https://www.ncbi.nlm.nih.gov/pubmed/32872144 http://dx.doi.org/10.3390/biomedicines8090312

Ejemplares similares

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course
por: Huss, André, et al.
Publicado: (2020)

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
por: Abdelhak, Ahmed, et al.
Publicado: (2015)

Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing
por: Bachhuber, Franziska, et al.
Publicado: (2021)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
por: Senel, Makbule, et al.
Publicado: (2019)

Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report
por: Rapp, Daniel, et al.
Publicado: (2020)

Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease
por: Huss, André, et al.
Publicado: (2022)

Serum GFAP as a biomarker for disease severity in multiple sclerosis
por: Abdelhak, A., et al.
Publicado: (2018)

Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
por: Senel, Makbule, et al.
Publicado: (2014)

Varicella zoster virus-induced neurological disease after COVID-19 vaccination: a retrospective monocentric study
por: Abu-Rumeileh, Samir, et al.
Publicado: (2021)

Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
por: Abdelhak, A., et al.
Publicado: (2019)

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
por: Abdelhak, Ahmed, et al.
Publicado: (2020)

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
por: Brettschneider, Johannes, et al.
Publicado: (2010)

Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS
por: Aktas, Orhan, et al.
Publicado: (2020)

Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial
por: Dorst, Johannes, et al.
Publicado: (2019)

Tick-Borne Encephalitis: A Differential Pattern of Intrathecal Humoral Immune Response and Inflammatory Cell Composition Compared with Other Viral CNS Infections
por: Senel, Makbule, et al.
Publicado: (2020)

Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
por: Dorst, Johannes, et al.
Publicado: (2023)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
por: Robinson, Tilman, et al.
Publicado: (2020)

Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases – a retrospective cross-sectional study
por: Brauchle, Felix, et al.
Publicado: (2023)

The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis
por: Castellazzi, Massimiliano, et al.
Publicado: (2022)

Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases
por: Dorst, Johannes, et al.
Publicado: (2020)

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome
por: Brettschneider, Johannes, et al.
Publicado: (2009)

Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies
por: Davies, Alexander J., et al.
Publicado: (2020)

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
por: Abdelhak, Ahmed, et al.
Publicado: (2019)

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Optical coherence tomography-based assessment of retinal vascular pathology in cerebral small vessel disease
por: Abdelhak, A., et al.
Publicado: (2020)

Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
por: Abu-Rumeileh, Samir, et al.
Publicado: (2020)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
por: Klose, Veronika, et al.
Publicado: (2023)

Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression—A Case Report
por: Jesse, Sarah, et al.
Publicado: (2021)

Differential Expression of Serum Extracellular Vesicle miRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology
por: Cuomo-Haymour, Nagiua, et al.
Publicado: (2022)

Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway
por: Luo, Yi, et al.
Publicado: (2021)

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood
por: Fazeli, Badrieh, et al.
Publicado: (2023)

Longitudinal monitoring of amyotrophic lateral sclerosis by diffusion tensor imaging: Power calculations for group studies
por: Behler, Anna, et al.
Publicado: (2022)

Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19
por: Abu-Rumeileh, Samir, et al.
Publicado: (2020)

Communicating Hydrocephalus Following Eosinophilic Meningitis Is Pathogenic for Chronic Viliuisk Encephalomyelitis in Northeastern Siberia
por: Storch, Alexander, et al.
Publicado: (2014)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study
por: Müller, Hans-Peter, et al.
Publicado: (2018)

Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials
por: Witzel, Simon, et al.
Publicado: (2021)

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
por: Jesse, Sarah, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1ha7t9msj6mff4elnav6101otr